Gee AP - Search Results

1

Product release assays.

Gee AP. Gee AP. Cytotherapy. 1999;1(6):485-91. doi: 10.1080/0032472031000141309. Cytotherapy. 1999. PMID: 20426549 No abstract available.

2

Mesenchymal stromal cell secretomes are modulated by suspension time, delivery vehicle, passage through catheter, and exposure to adjuvants.

Parsha K, Mir O, Satani N, Yang B, Guerrero W, Mei Z, Cai C, Chen PR, Gee A, Hanley PJ, Aronowski J, Savitz SI. Parsha K, et al. Cytotherapy. 2017 Jan;19(1):36-46. doi: 10.1016/j.jcyt.2016.10.006. Epub 2016 Nov 14. Cytotherapy. 2017. PMID: 27856228

3

Bone marrow-derived mononuclear cell populations in pediatric and adult patients.

Harting MT, Cox CS, Day MC, Walker P, Gee A, Brenneman MM, Grotta JC, Savitz SI. Harting MT, et al. Cytotherapy. 2009;11(4):480-4. doi: 10.1080/14653240902960452. Cytotherapy. 2009. PMID: 19462318

4

Developments in clinical cell therapy.

Stroncek D, Berlyne D, Fox B, Gee A, Heimfeld S, Lindblad R, Loper K, McKenna D Jr, Rooney C, Sabatino M, Wagner E, Whiteside T, Wood D, Heath-Mondoro T. Stroncek D, et al. Cytotherapy. 2010 May;12(3):425-8. doi: 10.3109/14653240903511952. Cytotherapy. 2010. PMID: 20078383 Free PMC article.

5

Gene transfer: regulatory issues and their impact on the clinical investigator and the good manufacturing production facility.

Grilley BJ, Gee AP. Grilley BJ, et al. Among authors: gee ap. Cytotherapy. 2003;5(3):197-207. doi: 10.1080/14653240310001271. Cytotherapy. 2003. PMID: 12850787 Review.

6

A multicenter comparison study between the Endosafe PTS rapid-release testing system and traditional methods for detecting endotoxin in cell-therapy products.

Gee AP, Sumstad D, Stanson J, Watson P, Proctor J, Kadidlo D, Koch E, Sprague J, Wood D, Styers D, McKenna D, Gallelli J, Griffin D, Read EJ, Parish B, Lindblad R. Gee AP, et al. Cytotherapy. 2008;10(4):427-35. doi: 10.1080/14653240802075476. Cytotherapy. 2008. PMID: 18574775 Free PMC article.

7

Manufacturing genetically modified T cells for clinical trials.

Gee AP. Gee AP. Cancer Gene Ther. 2015 Mar;22(2):67-71. doi: 10.1038/cgt.2014.71. Epub 2015 Jan 30. Cancer Gene Ther. 2015. PMID: 25633481 Review.

8

T-cell immunotherapy for adenoviral infections of stem-cell transplant recipients.

Leen AM, Myers GD, Bollard CM, Huls MH, Sili U, Gee AP, Heslop HE, Rooney CM. Leen AM, et al. Among authors: gee ap. Ann N Y Acad Sci. 2005 Dec;1062:104-15. doi: 10.1196/annals.1358.013. Ann N Y Acad Sci. 2005. PMID: 16461793 Review.

9

What a cell-processing laboratory can and can't do for cellular therapy.

Gee AP. Gee AP. Cytotherapy. 2002;4(5):447-8. doi: 10.1080/146532402320776143. Cytotherapy. 2002. PMID: 12473221 No abstract available.

10

Immune therapy for EBV infections after hemopoietic stem-cell transplant.

Heslop HE, Bollard CM, Gottschalk S, Kuehnle I, Huls MH, Gee AP, Brenner MK, Rooney CM. Heslop HE, et al. Among authors: gee ap. Cytotherapy. 2002;4(5):433-4. doi: 10.1080/146532402320776071. Cytotherapy. 2002. PMID: 12473214 Review. No abstract available.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

Search Page

Search Results